Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Dmitry I. Gabrilovich(AstraZeneca (Netherlands)), W. Martin Kast(University of Southern California), Eduardo M. Sotomayor(Tampa General Hospital), Markwin P. Velders(Loyola University Chicago)
Cited by 533
Related Papers
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected
|Journal of Clinical Investigation|2015|1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
MyD88-dependent expansion of an immature GR-1+CD11b+ population induces T cell suppression and Th2 polarization in sepsis
|The Journal of Experimental Medicine|2007|647